Oncology Competitor Counter-Detail Builder
Generate evidence-based competitive rebuttals for oncology sales conversations instantly.
What You Can Do
You can rapidly construct evidence-based competitive responses that address specific oncologist objections with clinical parity analysis, head-to-head trial comparisons, and safety contextualization. The skill generates 2-3 minute talking points that distinguish your oncology drug on meaningful endpoints while flagging claims requiring medical science liaison support or printed evidence—ensuring your counter-details hold up to regulatory scrutiny without crossing into prohibited promotional territory.
Features
Side-by-side comparison of your drug versus competitor on efficacy endpoints, progression-free survival, overall survival, and response rates for specific patient populations
Automatic flagging of claims requiring medical science liaison escalation, printed evidence support, or REMS documentation before delivery
Identifies which patient subgroups benefit most from your drug and which may be better served by competitor options, supporting ethical positioning
Frames efficacy within the unique safety monitoring, pharmacovigilance, and access requirements of your drug versus competitor alternatives
Structures rebuttals around published pivotal trials, real-world evidence studies, and guideline positioning with specific data point citations
Generates speaking points for competitive scenarios in multi-specialty team settings with oncologist, pathologist, and other stakeholder objections pre-addressed
Incorporates post-market effectiveness data, observational studies, and registry data to support efficacy claims beyond pivotal trial populations
Example Output
Example 1 — Response to KEYNOTE Trial Objection
Doctor says: "Your competitor's KEYNOTE study showed a 40% response rate. Yours was only 32%."
Your counter-detail: "The KEYNOTE population was PD-L1 positive, high-burden disease. In our head-to-head Phase 3 subgroup of PD-L1 positive patients, response rates were comparable at 38%, but our median progression-free survival was 14.2 months versus 11.8 months in their data. Plus, their REMS program requires monthly imaging for safety monitoring—our protocol allows quarterly assessments once stable, which improves real-world adherence."
Example 2 — REMS Complexity Objection
Doctor says: "Your competitor's REMS is simpler. We're thinking of switching."
Your counter-detail: "I understand—REMS burden matters to your infusion center. Ours does require baseline and periodic liver monitoring, but that overlaps with standard care panels for oncology patients anyway. What's different: our real-world data from 2,400 patients showed 94% completion rates because monitoring integrated into routine labs. Their simpler REMS reflects a different safety profile—more baseline hepatotoxicity events in trials. Happy to connect our medical science team to review your specific workflow and see where we can streamline."
Example 3 — Patient Population Qualifier
Doctor says: "Should I use your drug or their drug for this BRCA-wild-type patient?"
Your counter-detail: "Great question. For BRCA-wild-type patients, our data shows best benefit in those with high mutational burden—median OS benefit is 5.2 months. Their drug showed stronger benefit in BRCA-mutant patients, around 7 months OS improvement. For your specific patient, I'd actually lean toward their option based on the tumor profile we discussed. But if you see a high-burden wild-type patient next, ours typically outperforms in our real-world cohort."
What's Included
- SKILL.md instruction file: Complete framework for structuring competitive responses with compliance checkpoints
- Clinical parity comparison template: Side-by-side trial data structure for efficacy, safety, and REMS comparison
- Compliance guardrail checklist: Flags claims requiring MSL escalation, printed evidence, or additional regulatory support
- Patient population qualifier workflow: Decision tree for identifying which patient subgroups fit your drug versus competitor alternatives
- Tumor board talking point template: Pre-built responses for common multi-specialty objections with citations
Who It's For
- Oncology field sales representatives responding to real-time competitive objections during office visits
- Regional or territory managers preparing account teams for high-risk accounts with competitor market share
- Inside sales specialists supporting external reps with rapid competitive intelligence during Zoom or phone calls
- Medical science liaisons briefing field teams before tumor board presentations or clinical advisory board meetings
- New oncology reps building confidence in competitive positioning during early-career ramp
Best For
- Real-time competitive rebuttals during oncologist objections in office or virtual settings
- Pre-visit account planning for known competitive threats or switching risk
- Tumor board preparation where multiple competing drugs will be discussed
- Published trial or guideline objection responses requiring clinical evidence grounding
- Patient population qualification conversations to identify best-fit candidates for your drug
You might also like
Transform scattered clinical research into structured, evidence-based summaries tailored for healthcare decision-making. This skill automatically assesses study quality, evaluates potential biases, and grades the strength of evidence using standardized frameworks like GRADE. You get synthesis ready to inform clinical decisions, guideline updates, or research protocols—all with transparent reasoning about confidence levels and limitations.
by killvault
This skill automates the complete lifecycle of electronic records—from classification and retention scheduling to audit logging and compliant disposal. You provide record metadata or policy requirements, and Claude generates classification matrices, retention schedules, compliance assessments, and disposal workflows tailored to regulations like GDPR, HIPAA, and SOX. It eliminates manual record management and ensures your organization never misses retention deadlines or violates regulatory holds.
by killvault
Create comprehensive community programming strategies that strengthen public library engagement and impact. Generate program proposals, needs assessments, marketing plans, and evaluation frameworks tailored to your library's specific community. Develop actionable plans for diverse programming initiatives—from literacy programs to digital literacy workshops to family events—with built-in accessibility and inclusion considerations.
by killvault
You can develop comprehensive research guides tailored to specific subjects or disciplines, and design complete information literacy curricula that teach students critical evaluation and research skills. The skill generates learning objectives, assessment strategies, activity ideas, and frameworks aligned with established information literacy standards. It helps academic librarians, educators, and curriculum designers create structured programs that measurably improve student research competency.
by killvault
You convert raw clinical trial data, competitive intelligence, and patient population insights into concise, compliance-vetted talking points designed for high-stakes oncologist conversations. Claude helps you anticipate objections, address specific HCP resistance patterns, and build defensible clinical rationale for prescribing decisions—all within the time constraints of busy oncology practices.
by killvault
Evaluate your collections for preservation risks and generate prioritized, data-driven digitization strategies. This workflow synthesizes conservation assessments, stakeholder perspectives, and collection metadata into a comprehensive prioritization matrix and multi-phase digitization roadmap. You'll get actionable recommendations backed by risk scores and impact assessments.
by killvault
Create professional institutional policies, detailed finding aids, accession records, and collection management documentation tailored to your special collections. You'll produce compliance-ready policies, descriptive guides that improve discoverability, and standardized documentation frameworks that streamline collection administration.
by killvault
You can rapidly map the clinical, pharmacy, and procurement decision-makers at target hospital systems, assemble persuasive health economic and clinical evidence tailored to each stakeholder's priorities, and develop presentation strategies that address objections before committee meetings occur. This skill compresses typical 6+ month formulary cycles into 2-3 meeting cycles by organizing evidence strategically and anticipating pharmacoeconomic scrutiny.
by killvault